Clinical Trial Update: Artificial Intelligence to StrategiCally Enhance Pulmonary Embolism Response Team Activation [NA]

View source ↗

Summary

A clinical trial evaluating artificial intelligence to strategically enhance Pulmonary Embolism Response Team activation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Pulmonary Embolism Subacute Massive | NA | Status: WITHDRAWN